We are live on ! Find out more
ARMP icon

Armata Pharmaceuticals

36 hedge funds and large institutions have $7.85M invested in Armata Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 11 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,000% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 1

245% more capital invested

Capital invested by funds: $2.27M → $7.85M (+$5.58M)

200% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 4

29% more funds holding

Funds holding: 2836 (+8)

1.33% more ownership

Funds ownership: 2.1%3.43% (+1.3%)

Holders
36
Holders Change
+8
Holders Change %
+28.57%
% of All Funds
0.44%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
11
Reduced
1
Closed
4
Calls
Puts
Net Calls
Net Calls Change

ARMP Hedge Fund Activity: Q4 2025 in Review

36 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in Armata Pharmaceuticals (ARMP) for Q4 2025, worth a combined $7.85M — up 245% from $2.27M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new ARMP positions and 4 closed out — a net gain of 8 holders — while 11 added to existing stakes and 1 trimmed.

The largest buyer was 683 Capital Management, opening a new position worth an estimated $766K. The largest seller was Group One Trading, exiting entirely with an estimated $8.94K sold.

  • 36 institutional investors held Armata Pharmaceuticals (ARMP) as of Q4 2025, up from 28 in Q3 2025.
  • Funds reported $7.85M of Armata Pharmaceuticals stock for Q4 2025, up 245% quarter-over-quarter.
  • 12 funds opened new Armata Pharmaceuticals positions in Q4 2025 and 4 closed out, a net change of +8 holders.
  • The largest Armata Pharmaceuticals buyer in Q4 2025 was 683 Capital Management, an estimated $766K added.
  • The largest Armata Pharmaceuticals seller in Q4 2025 was Group One Trading, an estimated $8.94K sold.

Based on aggregated 13F filings for Q4 2025.